NO996366L - Arylkarboksylsyre- og tetrazolderivater - Google Patents

Arylkarboksylsyre- og tetrazolderivater

Info

Publication number
NO996366L
NO996366L NO996366A NO996366A NO996366L NO 996366 L NO996366 L NO 996366L NO 996366 A NO996366 A NO 996366A NO 996366 A NO996366 A NO 996366A NO 996366 L NO996366 L NO 996366L
Authority
NO
Norway
Prior art keywords
carboxylic acid
aryl carboxylic
tetrazole derivatives
tetrazole
derivatives
Prior art date
Application number
NO996366A
Other languages
English (en)
Other versions
NO996366D0 (no
NO316171B1 (no
Inventor
Francisco Javier Lopez-Tapia
Alexander Victor Muehldorf
Counde O'yang
Daniel Lee Severance
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO996366D0 publication Critical patent/NO996366D0/no
Publication of NO996366L publication Critical patent/NO996366L/no
Publication of NO316171B1 publication Critical patent/NO316171B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
NO19996366A 1998-12-23 1999-12-21 Arylkarboksylsyre- og tetrazolderivater, farmasöytisk preparat samt fremgangsmåte for fremstilling og anvendelse derav NO316171B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11344698P 1998-12-23 1998-12-23
US15181499P 1999-08-30 1999-08-30

Publications (3)

Publication Number Publication Date
NO996366D0 NO996366D0 (no) 1999-12-21
NO996366L true NO996366L (no) 2000-06-26
NO316171B1 NO316171B1 (no) 2003-12-22

Family

ID=26811078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996366A NO316171B1 (no) 1998-12-23 1999-12-21 Arylkarboksylsyre- og tetrazolderivater, farmasöytisk preparat samt fremgangsmåte for fremstilling og anvendelse derav

Country Status (29)

Country Link
US (1) US6335459B1 (no)
EP (1) EP1013639B1 (no)
JP (1) JP3415085B2 (no)
KR (1) KR100378335B1 (no)
CN (1) CN1167670C (no)
AR (1) AR029320A1 (no)
AT (1) ATE251125T1 (no)
AU (1) AU735640B2 (no)
BR (1) BR9905974A (no)
CA (1) CA2292921C (no)
DE (1) DE69911726T2 (no)
DK (1) DK1013639T3 (no)
ES (1) ES2207108T3 (no)
HR (1) HRP990394A2 (no)
HU (1) HUP9904659A3 (no)
ID (1) ID25983A (no)
IL (1) IL133578A (no)
MA (1) MA26713A1 (no)
NO (1) NO316171B1 (no)
NZ (1) NZ501891A (no)
PE (1) PE20001368A1 (no)
PL (1) PL337419A1 (no)
PT (1) PT1013639E (no)
RU (1) RU2179969C2 (no)
SG (1) SG90086A1 (no)
TR (1) TR199903310A3 (no)
TW (1) TWI221834B (no)
UY (1) UY25876A1 (no)
YU (1) YU69699A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
EP1368345B1 (en) * 2001-03-02 2006-03-22 F. Hoffmann-La Roche AG Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
ES2636943T3 (es) 2003-05-09 2017-10-10 Toray Industries, Inc. Beraprost y un inhibidor del sistema renina-angiotensina para usar en el tratamiento de enfermedades renales
RU2268037C1 (ru) * 2004-04-22 2006-01-20 Германов Евгений Павлович Лекарственное средство
UA93548C2 (uk) 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
US9669381B2 (en) 2007-06-27 2017-06-06 Hrd Corporation System and process for hydrocracking
JP5536752B2 (ja) 2008-03-18 2014-07-02 アリーナ ファーマシューティカルズ， インコーポレイテッド プロスタサイクリン（ｐｇｉ２）受容体に関連する障害の処置に有用なｐｇｉ２受容体の調節因子
BRPI0916282B8 (pt) * 2008-07-23 2021-05-25 Toray Industries uso de um agonista do receptor-pgi2 no tratamento de insuficiência renal crônica
EP2995614B8 (en) 2010-06-11 2018-03-28 Rhodes Technologies Inc. Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
AU2011263416B2 (en) 2010-06-11 2014-04-10 Rhodes Technologies Process for N-dealkylation of tertiary amines
CN110582271B (zh) 2017-03-01 2022-06-14 阿瑞那制药公司 包含pgi2受体激动剂的组合物及其制备方法
KR20240149924A (ko) 2022-02-15 2024-10-15 유나이티드 세러퓨틱스 코오포레이션 결정질 프로스타시클린 (ip) 수용체 효능제 및 그의 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1079414A (en) 1965-06-30 1967-08-16 Smith & Nephew Derivatives of acetic acid and a process for their preparation
GB1185539A (en) 1967-11-03 1970-03-25 Smith & Nephew Substituted Tetrazoles
DE2432560A1 (de) 1974-07-06 1976-01-22 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeurederivate und verfahren zur herstellung derselben
JPS5832859A (ja) 1981-08-20 1983-02-25 Dainippon Pharmaceut Co Ltd Ｎ，ｎ−ジメチルカルバミン酸ベンジルエステル誘導体
JPH0725725B2 (ja) 1987-07-23 1995-03-22 保土谷化学工業株式会社 ベンズアミド誘導体
US5084466A (en) 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2090283A1 (en) 1992-02-28 1993-08-29 Nobuyuki Hamanaka Phenoxyacetic acid derivatives
EP0753528A4 (en) 1994-02-10 1999-03-10 Ono Pharmaceutical Co PROTAGLANDIN I 2? RECEPTOR
ATE205479T1 (de) 1994-03-10 2001-09-15 Fujisawa Pharmaceutical Co Naphtalen-derivate als prostaglandin i2 agonisten
US5753700A (en) 1994-12-28 1998-05-19 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
US6018068A (en) 1995-07-26 2000-01-25 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and drugs comprising the same as active ingredients
DE19619445C1 (de) * 1996-05-14 1997-09-25 Bayer Ag Verfahren zur Herstellung von optisch aktiver N-Phenylcarbamat-milchsäure
AUPP029197A0 (en) 1997-11-10 1997-12-04 Fujisawa Pharmaceutical Co., Ltd. Benzocycloheptene derivatives
AUPP109097A0 (en) 1997-12-22 1998-01-22 Fujisawa Pharmaceutical Co., Ltd. Napthalene derivatives

Also Published As

Publication number Publication date
NO996366D0 (no) 1999-12-21
BR9905974A (pt) 2000-09-12
DK1013639T3 (da) 2004-02-09
TR199903310A2 (xx) 2000-10-23
PL337419A1 (en) 2000-07-03
SG90086A1 (en) 2002-07-23
NO316171B1 (no) 2003-12-22
CA2292921A1 (en) 2000-06-23
CN1266054A (zh) 2000-09-13
JP2000191523A (ja) 2000-07-11
CN1167670C (zh) 2004-09-22
DE69911726T2 (de) 2004-07-29
JP3415085B2 (ja) 2003-06-09
EP1013639A1 (en) 2000-06-28
HUP9904659A3 (en) 2000-12-28
AU6534099A (en) 2000-07-06
ATE251125T1 (de) 2003-10-15
ES2207108T3 (es) 2004-05-16
HU9904659D0 (en) 2000-02-28
KR100378335B1 (ko) 2003-03-29
HRP990394A2 (en) 2000-08-31
PT1013639E (pt) 2004-02-27
IL133578A0 (en) 2001-04-30
YU69699A (sh) 2001-12-26
EP1013639B1 (en) 2003-10-01
CA2292921C (en) 2004-08-17
IL133578A (en) 2004-07-25
DE69911726D1 (de) 2003-11-06
HUP9904659A2 (hu) 2000-11-28
RU2179969C2 (ru) 2002-02-27
NZ501891A (en) 2001-10-26
MA26713A1 (fr) 2004-12-20
PE20001368A1 (es) 2000-12-14
AU735640B2 (en) 2001-07-12
KR20000048322A (ko) 2000-07-25
ID25983A (id) 2000-11-16
UY25876A1 (es) 2001-07-31
TR199903310A3 (tr) 2000-10-23
US6335459B1 (en) 2002-01-01
TWI221834B (en) 2004-10-11
AR029320A1 (es) 2003-06-25

Similar Documents

Publication Publication Date Title
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
DE69918278D1 (de) Substituierte indolalkansäure
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
ATE228995T1 (de) Aminomethylcarbonsäurederivate
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
DE69813570D1 (de) 5-alkyl-2-arylaminophenylessigsäure und derivative
NO20000877D0 (no) Forbedret syrekorrosjonsinhibitor
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
IS2231B (is) Nýjar amínóprópýlfosfínsýrur
DE60043730D1 (de) Arylsulfonamid-substituierte hydroxamsäure-derivate
NO996366D0 (no) Arylkarboksylsyre- og tetrazolderivater
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
DE60024754D1 (de) Aufzeichnungsgerät
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
DE69718338D1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate
NO994386D0 (no) 2-substituerte benzoylcykloalkyl-1-karboksylsyrederivater
FR2791941B3 (fr) Remorque
DE60030196D1 (de) Aufzeichnungsgerät
EE04061B1 (et) Metüleenbisfosfoonhappe derivaadid
DE69713354D1 (de) Hydroxamsäure-derivate
ZA997773B (en) Aryl carboxylic acid and tetrazole derivatives.
BR1100402A (pt) Derivados do ácido quinolona carboxìlico
SE9801991D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative II